New technology for separating and enriching biological materials using sound waves
Acoustic platform for separation, isolation, and enrichment in biomedical research
This study is working on a new technology that uses sound waves to help scientists easily sort and study important biological materials, like cancer cells, which could lead to better tests and treatments for patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11109406 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative acoustic microfluidic platform that can manipulate and analyze biological materials without contact or labels. By utilizing a novel standing acoustic wave technology, the platform aims to separate and enrich various biological samples, such as cancer cells and antibodies, in a highly efficient manner. The project will create prototype systems that can perform high-throughput analyses and real-time monitoring, making it valuable for researchers in cancer biology, synthetic biochemistry, and microbiology. Patients may benefit indirectly through advancements in diagnostics and treatment options derived from improved research capabilities.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients with cancer or other conditions requiring precise biological analysis.
Not a fit: Patients with conditions that do not involve biological material separation or enrichment may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic tools and treatments for various diseases, including cancer.
How similar studies have performed: Other research in acoustic microfluidics has shown promise in enhancing biological analysis, indicating that this approach could be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Meacham, John Mark — Washington University
- Study coordinator: Meacham, John Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.